EUROPE-COM : draft list of co-formulants banned in PPP

Published by Karine Mavet at 26 July 2019

The EU draft regulation implementing the list of co-formulants that shall not be used in plant protection products or adjuvants (Annex III of Regulation (EC) No. 1107/2009) was discussed in the SCoPAFF meeting of 16 and 17 July 2019.

Co-formulants are unacceptable in plant protection products if it is established that their use or their residues have a harmful effect on human or animal health or have an unacceptable effect on plants or on the environment.

According to the draft list, the following co-formulants are considered as unacceptable:

– substances with a harmonized classification as carcinogens, category 1A or 1B, or as cell mutagens, category 1A or 1B, or as toxic to reproduction, category 1A or 1B,

– substances identified as persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB),

– substances identified as substances of very high concern due to endocrine disrupting properties,

– substances identified as Persistent Organic Pollutants (POP),

– substances restricted under REACH where their use as a co-formulant in plant protection products is covered by the restriction,

– substances already identified as unacceptable co-formulants for plant protection products by Member States (Austria, Belgium, France, Germany, Italy, Lithuania, Spain and Norway) or during the renewal of approval process of active substance (i.e. POE-tallowamines),

– in-can preservatives that were not approved under the Biocide Regulation (EU) No 528/2012 due to unacceptable risks for human health and the environment (i.e. PHMB),

The draft regulation sets that unacceptable co-formulants may be present as unintentional impurities in other co-formulants provided their individual concentration in the finished plant protection product or adjuvant is less than 0.01 % (w/w) unless a different LoQ (Limit of Quantification) is provided.

At last, the draft Regulation sets that Member States must withdraw authorisations of products containing any of the listed unacceptable co-formulants at the latest by 2 years after entry into force of the list. A grace period of 12 months may be granted.

To download:

Draft Commission Regulation modifying Annex III of Regulation (EC) 1107/2009 and its Annex

Lynxee consulting’s team is at your disposal to answer your questions.

Contact us! https://lynxee.consulting/en/contact/